Buscar
Mostrando ítems 41-50 de 620
Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis
(Nature, 2019-03)
Hyaluronic acid (HA) is a glycosaminoglycan of extracellular matrix related to cell surface which interacts with various cell types. To understand the role of HA during hepatocarcinogenesis, we assessed the effect of the ...
Clinical - Pathological aspects of hepatocellular carcinoma in cattle
(2019-01-01)
Background: The hepatocellular carcinoma (HCC) is a malignant neoplasm of hepatocytes of rare occurrence in farm animals, with ruminants being the most affected species. This neoplasm is characterized by nonspecific symptoms ...
Results of liver transplantation for hepatocellular carcinoma in a multicenter latin American cohort study
(Mexican Assoc Hepatology, 2018)
Background and aims. Background and aims. He Background and aims. terogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma
(HCC) in Latin America. We aimed to describe treatment ...
Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
(2018)
Background and aims. Heterogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence ...
Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells
(Wiley, 2010-06)
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer-related death worldwide. Current treatments are extremely disappointing. SPARC (Secreted protein, acidic and rich in ...
Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report
(Sociedade Brasileira de Medicina Tropical, 2018)
INTRODUCTION: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with ...
Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration
(Nature Publishing Group, 2019-02)
Hepatocellular carcinoma (HCC) is a highly metastatic cancer with very poor prognosis. AMP activated kinase (AMPK) constitutes a candidate to inhibit HCC progression. First, AMPK is downregulated in HCC. Second, glucose ...
Hepatocellular carcinoma is rarely present in Western Mexico
(1999)
Hepatocellular carcinoma (HCC) is considered uncommon in most countries of Latin-America. The aim of this study was to analyze the frequency of HCC in Western Mexico and to evaluate the use of molecular markers - albumin ...
Hepatocellular carcinoma is rarely present in Western Mexico
(1999)
Hepatocellular carcinoma (HCC) is considered uncommon in most countries of Latin-America. The aim of this study was to analyze the frequency of HCC in Western Mexico and to evaluate the use of molecular markers - albumin ...
New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma
(2020-12-01)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in the world, and about 80% of the cases are associated with hepatitis B or C. Genetic and epigenetic alterations are accumulated over decades ...